KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Amortizatization of Intangibles (2018 - 2025)

Historic Amortizatization of Intangibles for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to $2.6 million.

  • Aurinia Pharmaceuticals' Amortizatization of Intangibles fell 2326.81% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year decrease of 1710.96%. This contributed to the annual value of $12.7 million for FY2024, which is 485.96% up from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Amortizatization of Intangibles stood at $2.6 million for Q3 2025, which was down 2326.81% from $2.6 million recorded in Q2 2025.
  • Aurinia Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $3.4 million during Q3 2024, with a 5-year trough of -$1.6 million in Q4 2021.
  • Over the past 5 years, Aurinia Pharmaceuticals' median Amortizatization of Intangibles value was $2.6 million (recorded in 2023), while the average stood at $1.8 million.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first tumbled by 19365.67% in 2022, then surged by 162913.91% in 2023.
  • Aurinia Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at -$1.6 million in 2021, then soared by 199.74% to $1.6 million in 2022, then skyrocketed by 112.13% to $3.3 million in 2023, then dropped by 9.86% to $3.0 million in 2024, then fell by 11.88% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q3 2025, $2.6 million for Q2 2025, and $2.7 million during Q1 2025.